Biocardia Correlations
BCDA Stock | USD 2.66 0.04 1.53% |
The correlation of Biocardia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Biocardia Correlation With Market
Significant diversification
The correlation between Biocardia and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biocardia and DJI in the same portfolio, assuming nothing else is changed.
Biocardia |
Moving together with Biocardia Stock
Moving against Biocardia Stock
0.6 | VINC | Vincerx Pharma | PairCorr |
0.54 | ME | 23Andme Holding | PairCorr |
0.53 | VKTX | Viking Therapeutics | PairCorr |
0.48 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.45 | DSGN | Design Therapeutics | PairCorr |
0.41 | DRRX | Durect Earnings Call This Week | PairCorr |
0.38 | SABSW | SAB Biotherapeutics | PairCorr |
0.37 | DNLI | Denali Therapeutics | PairCorr |
0.32 | VCYT | Veracyte | PairCorr |
0.6 | VTRS | Viatris | PairCorr |
0.54 | VTYX | Ventyx Biosciences | PairCorr |
0.45 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.45 | ELAN | Elanco Animal Health | PairCorr |
0.37 | VRDN | Viridian Therapeutics Downward Rally | PairCorr |
0.35 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.35 | VYNE | Vyne Therapeutics | PairCorr |
0.33 | VRAX | Virax Biolabs Group | PairCorr |
0.31 | DYAI | Dyadic International Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biocardia Stock performing well and Biocardia Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biocardia's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
AVTE | 1.30 | (0.04) | 0.00 | (0.22) | 0.00 | 2.07 | 10.45 | |||
ADAG | 3.05 | (0.08) | 0.00 | 0.25 | 0.00 | 4.62 | 41.45 | |||
ACRV | 4.16 | (0.07) | 0.00 | (0.14) | 0.00 | 10.17 | 30.57 | |||
RZLT | 3.05 | (0.41) | 0.00 | (0.51) | 0.00 | 5.62 | 22.04 | |||
ANTX | 2.46 | (0.01) | 0.00 | (0.12) | 0.00 | 5.41 | 17.09 | |||
ZIVO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
THRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ERAS | 3.31 | (0.86) | 0.00 | (0.70) | 0.00 | 7.57 | 21.39 | |||
FBRX | 4.98 | (1.92) | 0.00 | (3.26) | 0.00 | 8.94 | 28.46 | |||
AMTI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Biocardia Corporate Management
Edward Gillis | Senior Devices | Profile | |
Ian McNiece | Chief Officer | Profile | |
Sujith Shetty | Chief Regulatory | Profile | |
Sujith MBBS | Chief Regulatory | Profile |